Čájehuvvojit 1 - 3 oktiibuot 3 bohtosis ohcui Isabelle Schomaecker', ohcanáigi: 0,02s Aiddostahte ozu
  1. 1
    The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study

    The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study Dahkki Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Dietmar Rosenthal, Sara Samadzadeh

    Almmustuhtton 2022-01-01
    Viečča ollesdeavstta
    Artihkal
  2. 2
    The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia

    The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia Dahkki Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Dietmar Rosenthal, Sara Samadzadeh

    Almmustuhtton 2021-07-01
    Viečča ollesdeavstta
    Artihkal
  3. 3
    Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study

    Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study Dahkki Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Beyza Ürer, Raphaela Brauns, Dietmar Rosenthal, Philipp Albrecht, Sara Samadzadeh

    Almmustuhtton 2023-06-01
    Viečča ollesdeavstta
    Artihkal

Ohcanreaiddut: